Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis

World J Urol. 2015 Nov;33(11):1807-14. doi: 10.1007/s00345-015-1538-z. Epub 2015 Mar 25.

Abstract

Purpose: Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma is unclear. To assess whether PN provides adequate cancer control in high-risk disease (HRD), survival outcomes were compared in both a population-based cohort and an institutional cohort.

Methods: Surveillance, Epidemiology, and End Results database and a prospectively maintained institutional database were queried for patients with RCC who underwent PN or RN for a localized tumor ≤7 cm and were found to have high-grade and/or high-stage disease (HRD). Cancer-specific (CSS) or recurrence-free survival (RFS) and overall survival (OS) were primary outcomes measured and were compared between those who underwent PN and RN using multivariable Cox proportional hazards and propensity analysis.

Results: The population cohort consisted of 12,757 (24.9 %) patients with HRD, 85.2 and 14.8 % of which underwent RN and PN, respectively. RN was not associated with CSS (HR 1.23, p = 0.08) but was independently associated with poor OS (HR 1.16, p = 0.031). Propensity analysis showed that RN resulted in a 20 % increased risk of death from all causes (p = 0.008). In the institutional cohort, of 317 patients, 35.9 % had HRD, 56 and 52 of which underwent RN and PN, respectively. Adjusting for age-adjusted Charlson index, RN was a predictor of poor OS (OR 6.20, p = 0.041). Propensity analysis showed that RFS and OS were not related to nephrectomy type (RN HR 0.65, p = 0.627 and RN HR 1.70, p = 0.484).

Conclusions: In patients with pathologic high-risk RCC, partial excision is associated with similar cancer control as compared to radical excision.

Keywords: Complications; Mortality; Nephrectomy; Outcomes; Renal cell carcinoma.

MeSH terms

  • Carcinoma, Renal Cell / mortality
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / surgery*
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery*
  • Male
  • Middle Aged
  • Neoplasm Staging / methods*
  • Nephrectomy*
  • New York / epidemiology
  • Population Surveillance / methods*
  • Postoperative Complications / epidemiology*
  • Prognosis
  • Propensity Score
  • Retrospective Studies
  • Risk Factors
  • SEER Program*
  • Survival Rate / trends
  • Time Factors